Rosen G, Murphy ML, Huvos AG, Gutierrez M, Marcove RC: Chemotherapy, en bloc resection, and prosthetic bone replacement in treatment of osteogenic sarcoma. Cancer. 1976, 37: 1-11.
Article
CAS
PubMed
Google Scholar
Link MP, Goorin AM, Horowitz M, Meyer WH, Belasco J, Baker A, Ayala A, Shuster J: Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the multi-institutional osteosarcoma study. Clin Orthop. 1991, 270: 8-14.
PubMed
Google Scholar
Provisor AJ, Ettinger LJ, Nachman JB, Krailo MD, Makley JT, Yunis EJ, Huvos AG, Betcher DL, Baum ES, Kisker CT, Miser JS: Treatment of non-metastatic osteosarcoma of the extremity with pre-operative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol. 1997, 15: 76-84.
CAS
PubMed
Google Scholar
Rosenberg SA, Spiess P, Lafreniere R: A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science. 1986, 233: 1318-1321.
Article
CAS
PubMed
Google Scholar
Aebersold P, Hyatt C, Johnson S, Hines K, Korcak L, Sanders M, Lotze M, Topalian S, Yang J, Rosenberg SA: Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response. J Natl Cancer Inst. 1991, 83: 932-937.
Article
CAS
PubMed
Google Scholar
Rosenberg SA: Progress in human tumour immunology and immunotherapy. Nature. 2001, 411: 380-384. 10.1038/35077246.
Article
CAS
PubMed
Google Scholar
Dudley ME, Wunderlich JR, Shelton TE, Even J, Rosenberg SA: Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients. J Immunother. 2003, 26: 332-342. 10.1097/00002371-200307000-00005.
Article
PubMed
PubMed Central
Google Scholar
Fabbri M, Ridolfi R, Maltino R, Ridolfi L, Riccobon A, Flamini E, De Paola F, Verdecchia GM, Amadori D: Tumor infiltrating lymphocytes and continous infusion interleukin-2 after metastasectomy in 61 patients with melanoma, colorectal and renal carcinoma. Tumori. 2000, 86: 46-52.
CAS
PubMed
Google Scholar
Huang J, Khong HT, Dudley ME, El-Gamil M, Li YF, Rosenberg SA, Robbins PF: Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression. J Immunother. 2005, 28: 258-267. 10.1097/01.cji.0000158855.92792.7a.
Article
CAS
PubMed
PubMed Central
Google Scholar
El Hage F, Vergnon I, Grunenwald D, Soria JC, Chouaib S, Mami-Chouaib F: Generation of diverse mutated tumor antigen-specific cytotoxic T lymphocytes in a lung cancer patient with long survival. Oncol Rep. 2005, 14: 763-769.
CAS
PubMed
Google Scholar
Dillma R, Schiltz P, DePriest C, Barth N, Beutel L, de Leon C, O'Connor A, Nayak S: Tumor-infiltrating lymphocytes and interleukin-2: dose and schedules of administration in the treatment of metastatic cancer. Cancer Biother Radiopharm. 2004, 19: 730-737. 10.1089/cbr.2004.19.730.
Article
Google Scholar
Kowalczyk D, Skorupski W, Kwias Z, Nowak J: Flow cytometric analysis of tumour-infiltrating lymphocytes in patients with renal cell carcinoma. Br J Urol. 1997, 80: 543-547.
Article
CAS
PubMed
Google Scholar
Dierderichsen AC, Zeuthen J, Christensen PB, Kristensen T: Characterization of tumour infiltrating lymphocytes and correlations with immunological surface molecules in colorectal cancer. Eur J Cancer. 1999, 35: 721-726. 10.1016/S0959-8049(99)00033-7.
Article
Google Scholar
Ikeguchi M, Oi K, Hirooka Y, Kaibara N: CD8+ lymphocyte infiltration and apoptosis in hepatocellular carcinoma. Eur J Surg Oncol. 2004, 30: 53-57. 10.1016/j.ejso.2003.10.001.
Article
CAS
PubMed
Google Scholar
Yakirevich E, Izhak OB, Rennert G, Kovacs ZG, Resnick MB: Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast. Mod Pathol. 1999, 12: 1050-1056.
CAS
PubMed
Google Scholar
Mercader M, Bodner BK, Moser MT, Kwon PS, Park ES, Manecke RG, Ellis TM, Wojcik EM, Yang D, Flanigan RC, Waters WB, Kast WM, Kwon ED: T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer. Proc Natl Acad Sci USA. 2001, 98: 14565-14570. 10.1073/pnas.251140998.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kobayashi M, Ito M, Sano K, Honda T, Nakayama J: Pulmonary lymphoepithelioma-like carcinoma: predominant infiltration of tumor-associated cytotoxic T lymphocytes might represent the enhanced tumor immunity. Intern Med. 2004, 43: 323-326. 10.2169/internalmedicine.43.323.
Article
PubMed
Google Scholar
Noonan K, Matsui W, Serafini P, Carbley R, Tan G, Khalifi J, Bonyhadi M, Levitsky H, Whartenby K, Borrelo I: Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors. Cancer Res. 2005, 65: 2026-2034. 10.1158/0008-5472.CAN-04-3337.
Article
CAS
PubMed
Google Scholar
Rivoltini L, Arienti F, Orazi A, Cefalo G, Gasparini M, Gambacorti-Passerini C, Fossati-Bellani F, Parmiani G: Phenotypic and functional analysis of lymphocytes infiltrating paediatric tumours, with a characterization of the tumour phenotype. Cancer Immunol Immunother. 1992, 34: 241-251. 10.1007/BF01741792.
Article
CAS
PubMed
Google Scholar
Zietz C, Rumpler U, Sturzl M, Lohrs U: Inverse relation of Fas-ligand and tumor-infiltrating lymphocytes in angiosarcoma: indications of apoptotic tumor counterattack. Am J Pathol. 2001, 159: 963-970.
Article
CAS
PubMed
PubMed Central
Google Scholar
Barber MR, Yang TJ: Tumor infiltrating lymphocytes: CD8+ lymphocytes in canine transmissible venereal sarcomas at different stages of tumor growth. Anticancer Res. 1999, 19: 1137-1142.
CAS
PubMed
Google Scholar
Yu R, Fujio K, Tahara H, Araki Y, Yamamoto K: Clonal dynamics of tumor-infiltrating lymphocytes. Eur J Immunol. 2005, 35: 1754-1763. 10.1002/eji.200425866.
Article
CAS
PubMed
Google Scholar
Rosenberg SA, Yannelli JR, Yang JC, Topalian SL, Schwartzentruber DJ, Weber JS, Parkinson DR, Seipp CA, Einhorn JH, White DE: Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2. J Natl Cancer Inst. 1994, 86: 1159-1166.
Article
CAS
PubMed
Google Scholar
Dreno B, Nguyen JM, Khammari A, Pandolfino MC, Tessier MH, Bercegeay S, Cassidanius A, Lemarre P, Billaudel S, Labarriere N, Jotereau F: Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma. Cancer Immunol Immunother. 2002, 51: 539-546. 10.1007/s00262-002-0315-1.
Article
CAS
PubMed
Google Scholar
Burger UL, Chang MP, Nagoshi M, Goedegebuure PS, Eberlein TJ: Improved in vivo efficacy of TIL after restimulation with irradiated tumor cells in vitro. Ann Surg Oncol. 1996, 3: 580-587.
Article
CAS
PubMed
Google Scholar
Harada M, Matsuzaki G, Shinomiya Y, Kurosawa S, Ito O, Okamoto T, Takenoyama M, Sumitika H, Nishimura Y, Nomoto K: Generation of tumor-specific cytotoxic T lymphocytes in vivo combined treatment with inactivated tumor cells and recombinant interleukin-2. Cancer Immunol Immunother. 1994, 38: 332-338.
CAS
PubMed
Google Scholar
Yang JC, Perry-Lalley D, Rosenberg SA: An improved method for growing murine tumor-infiltrating lymphocytes with in vivo antitumor activity. J Biol Response Mod. 1990, 9: 149-159.
CAS
PubMed
Google Scholar
Rosenberg SA, Spiess P, Lafreniere R: A new approach to the adoptive immunotherapy of cancer with infiltrating lymphocytes. Science. 1986, 233: 1318-1321.
Article
CAS
PubMed
Google Scholar
Klein B, Pals S, Masse R, Lafuma J, Morin M, Binart N, Jasmin JR, Jasmin C: Studies of bone and soft-tissue tumours induced in rats with radioactive cerium chloride. Int J Cancer. 1977, 20: 112-119.
Article
CAS
PubMed
Google Scholar
Thiéry J-P, Perdereau B, Gongora R, Gongora G, Mazabraud A: Un modèle experimental d'ostéosarcome chez le rat. II L'ostéosarcome greffable du rat. Sem Hôp Paris. 1982, 58: 1686-1689.
Google Scholar
Heymann D, Ory B, Blanchard F, Heymann MF, Coipeau P, Charrier C, Couillaud S, Thiéry JP, Gouin F, Rédini F: Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma. Bone. 2005, 37: 74-86. 10.1016/j.bone.2005.02.020.
Article
CAS
PubMed
Google Scholar
Lynch DH, Miller RE: Immunotherapeutic elimination of syngenic tumors in vivo by cytotoxic T lymphocytes generated in vitro from lymphocytes from the draining lymph nodes of tumor-bearing mice. Eur J Immunol. 1991, 21: 1403-1410.
Article
CAS
PubMed
Google Scholar
Melief CJ, Kast WM: T-cell immunotherapy of tumors by adoptive transfer of cytotoxic T lymphocytes and by vaccination with minimal essential epitopes. Immunol Rev. 1995, 145: 167-177.
Article
CAS
PubMed
Google Scholar
Rivoltini L, Arienti F, Orazi A, Cefalo G, Gasparini M, Gambacorti-Passerini C, Fossati-Bellani F, Parmiani G: Phenotypic and functional analysis of lymphocytes infiltrating paediatric tumours, with a characterization of the tumour phenotype. Cancer Immunol Immunother. 1992, 34: 241-251. 10.1007/BF01741792.
Article
CAS
PubMed
Google Scholar
Haanen JB, Baars A, Gomez R, Weber P, Smits M, de Gruijl TD, von Blomberg BM, Bloemena E, Scheper RJ, van Ham SM, Pinedo HM, van den Eertwegh AJ: Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients. Cancer Immunol Immunother.
Trieb K, Lechleitner T, Lang S, Windhager R, Kotz R, Dirnhofer S: Evaluation of HLA-DR expression and T-lymphocyte infiltration in osteosarcoma. Pathol Res Pract. 1998, 194: 679-684.
Article
CAS
PubMed
Google Scholar
Topalian SL, Muul LM, Rosenberg SA: Growth and immunological characteristics of lymphocytes infiltrating human tumors [abstract]. Surg Forum. 1987, 37: 390-
Google Scholar
Antony PA, Piccirillo CA, Akpinarli A, Finkelstein SE, Speiss PJ, Surman DR, Palmer DC, Chan CC, Klebanoff CA, Overwijk WW, Rosenberg SA, Resifo NP: CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. J Immunol. 2005, 174: 2591-601.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yu P, Lee Y, Liu W, Krusz T, Chong A, Schreiber H, Fu YX: Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J Exp Med. 2005, 201: 779-791. 10.1084/jem.20041684.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ormandy LA, Hillemann T, Wedemeyer H, Manns MP, Greten TF, Korangy F: Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res. 2005, 65: 2457-2464. 10.1158/0008-5472.CAN-04-3232.
Article
CAS
PubMed
Google Scholar
Kojima H, Kanno Y, Hase H, Kobata T: CD4+CD25+ regulatory T cells attenuate the phosphatidylinositol 3-kinase/Akt pathway in antigen-primed immature CD8+ CTLs during functional maturation. J Immunol. 2005, 174: 5959-5967.
Article
CAS
PubMed
Google Scholar
Erman SE, Sohn JJ, Rao VP, Nambiar PR, Ge Z, Fox JG, Schauer DB: CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice. Cancer Res. 2005, 65: 3998-4004. 10.1158/0008-5472.CAN-04-3104.
Article
Google Scholar
Sudo T, Kuramoto T, Komiya S, Inoue A, Itoh K: Expression of MAGE genes in osteosarcoma. J Orthop Res. 1997, 15: 128-132. 10.1002/jor.1100150119.
Article
CAS
PubMed
Google Scholar
Ishida H, Komiya S, Inoue Y, Yutani S, Inoue A, Itoh K: Expression of the SART1 tumor-rejection antigen in human osteosarcomas. Int J Oncol. 2000, 17: 29-32.
CAS
PubMed
Google Scholar
Tsuda N, Murayama K, Ishida H, Matsunaga K, Komiya S, Itoh K, Yamada A: Expression of a newly defined tumor-rejection antigen SART3 in musculoskeletal tumors and induction of HLA class I-restricted cytotoxic T lymphocytes by SART3-derived peptides. J Orthop Res. 2001, 19: 346-351. 10.1016/S0736-0266(00)90031-7.
Article
CAS
PubMed
Google Scholar
Tsukahara T, Nabeta Y, Kawaguchi S, Ikeda H, Sato Y, Shimozawa K, Ida K, Asanuma H, Hirohashi Y, Torigoe T, Hiraga H, Nagoya S, Wada T, Yamashita T, Sato N: Identification of human autologous cytotoxic T-lymphocyte-defined osteosarcoma gene that encodes a transcriptional regulator, papillomavirus binding factor. Cancer Res. 2004, 64: 5442-5448. 10.1158/0008-5472.CAN-04-0522.
Article
CAS
PubMed
Google Scholar
Miyagi Y, Imai N, Sasatomi T, Yamada A, Mine T, Katagiri K, Nakagawa M, Muto A, Okouchi S, Isomoto H, Shirouzu K, Yamana H, Itoh K: Induction of cellular immune responses to tumor cells and peptides in colorectal cancer patients by vaccination with SART3 peptides. Clin Cancer Res. 2001, 7: 3950-3962.
CAS
PubMed
Google Scholar
Trieb K, Lang S, Kotz R: Heat-shock protein 72 in human osteosarcoma: T-lymphocytes reactivity and cytotoxicity. Pediatr Hematol Oncol. 2000, 17: 355-364. 10.1080/08880010050034283.
Article
CAS
PubMed
Google Scholar